Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2008

View Archived Issues

FDA assigns priority review status to sanofi-aventis' NDA for Multaq in atrial fibrillation

Study examines role of insulin signaling in early Alzheimer's disease

Studies in vitro, in vivo display activity of gamma-secretase inhibitor GSI-953

Novel vitamin/nutriceutical formulation improves cognitive decline and behavioral symptoms

Mechanism of action discovered for the novel TNF-alpha production inhibitor SA-13353

Recent highlights at Elan

Cortex reports positive results from RD-02 phase IIa clinical trial of Ampakine in RD

Sound's chemoprotectant drug cleared for phase II hearing loss trial

Hematide phase III program cleared to continue by DMC

Metabasis and Roche collaborate in HCV

New data on TMC-278, a next-generation NNRTI, presented at the International AIDS Conference

Xanodyne reports positive results from two phase III clinical trials of tranexamic acid

Geron initiates enrollment in phase I/II clinical trial of GRN-163L in breast cancer

GTC Biotherapeutics submits final portion of BLA for ATryn to FDA

Innocoll completes dosing in phase II clinical trial of CollaRx in postoperative pain

Archemix and Ribomic sign license agreement for aptamers against multiple targets

FDA extends review timeline by 3 months for Centocor's BLA for ustekinumab

Lixte's compounds for brain tumors demonstrate activity in pancreatic cancer models

Good antiviral activity of Achillion's elvucitabine in phase II study

Novel JAK3 inhibitors described in patent literature

Novel agents for diagnosis of AD discussed in Nihon Medi-Physics patent

New agents for gastrointestinal disorders revealed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...